New hope for advanced gut cancers? early trial tests targeted antibody
Disease control
Completed
This early-stage study tested a new drug called cabotamig in 33 adults with advanced cancers of the digestive system (like colon, pancreas, or liver) that had stopped responding to standard treatments. The goal was to see if the drug is safe and how it affects the body and tumors…
Phase: PHASE1 • Sponsor: Arbele Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC